Renaissance Technologies’s Bionano Genomics BNGO Stock Holding History

Renaissance Technologies’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.7K	Buy	51,100 +2,400	+5%	+$2.89K	﹤0.01%	3040
2026 Q1	$57K	Buy	48,700 +11,700	+32%	+$15K	﹤0.01%	3100
2025 Q4	$56.6K	Buy	+37,000	New	+$64K	﹤0.01%	3080
2025 Q1	–	Sell	-2,638	Closed	-$45.7K	–	3478
2024 Q4	$45.7K	Buy	+2,638	New	+$45.1K	﹤0.01%	3405
2024 Q1	–	Sell	-8,571	Closed	-$972K	–	3716
2023 Q4	$972K	Buy	+8,571	New	+$895K	﹤0.01%	2425
2022 Q4	–	Sell	-2,349	Closed	-$2.58M	–	4124
2022 Q3	$2.58M	Sell	2,349 -3,747	-61%	-$4.95M	﹤0.01%	1861
2022 Q2	$5.05M	Buy	6,096 +5,915	+3,268%	+$6.09M	0.01%	1550
2022 Q1	$281K	Buy	+181	New	+$244K	﹤0.01%	3497
2021 Q2	–	Sell	-15,811	Closed	-$76.7M	–	3467
2021 Q1	$76.7M	Buy	+15,811	New	+$89.1M	0.1%	221

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

EGM

Engineers Gate Manager New York $7.71B AUM 24.88% 1-Year Est. Return

Renaissance Technologies's BNGO Position: Q2 2026 in Review

Renaissance Technologies increased its Bionano Genomics (BNGO) stake by 4.9% in Q2 2026, buying an estimated $2.89K and bringing the position to 51,100 shares worth $57.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3040.

Renaissance Technologies first reported a position in BNGO in Q1 2021 and has held it in 9 quarters since. The position peaked at $76.7M in Q1 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

Renaissance Technologies held 51,100 shares of Bionano Genomics worth $57.7K as of Q2 2026.
Renaissance Technologies bought 2,400 Bionano Genomics shares in Q2 2026, an estimated $2.89K.
Bionano Genomics made up ﹤0.01% of Renaissance Technologies's portfolio in Q2 2026, its #3040 holding.
Renaissance Technologies first reported a position in Bionano Genomics in Q1 2021 and has held it in 9 quarters since.
Renaissance Technologies's Bionano Genomics position peaked at $76.7M in Q1 2021.
34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Renaissance Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.